articleThe LancetJun 1, 2013Closed access

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

KCKachit ChoopanyaMMMichael MartinPSPravan SuntharasamaiUSUdomsak SangkumPAPhilip A. Mock

Ministry of Public Health · Centers for Disease Control and Prevention · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,489
total citations
FWCI
97.23
Percentile
100%
References
33
Citations per year

Authors

17

Topics & keywords

Topics
Keywords
  • Medicine
  • Placebo
  • Incidence (geometry)
  • Adverse effect
  • Randomized controlled trial
  • Pre-exposure prophylaxis
  • Internal medicine
  • Human immunodeficiency virus (HIV)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding